GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » Equity-to-Asset

Centogene NV (Centogene NV) Equity-to-Asset : -0.21 (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Centogene NV's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-16.49 Mil. Centogene NV's Total Assets for the quarter that ended in Jun. 2023 was $77.89 Mil.

The historical rank and industry rank for Centogene NV's Equity-to-Asset or its related term are showing as below:

CNTG' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.21   Med: 0.36   Max: 0.51
Current: -0.21

During the past 7 years, the highest Equity to Asset Ratio of Centogene NV was 0.51. The lowest was -0.21. And the median was 0.36.

CNTG's Equity-to-Asset is ranked worse than
89.87% of 237 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs CNTG: -0.21

Centogene NV Equity-to-Asset Historical Data

The historical data trend for Centogene NV's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Equity-to-Asset Chart

Centogene NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial 0.36 0.51 0.43 0.30 0.08

Centogene NV Quarterly Data
Dec17 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.30 0.23 0.08 -0.21

Competitive Comparison of Centogene NV's Equity-to-Asset

For the Diagnostics & Research subindustry, Centogene NV's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centogene NV's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Centogene NV's Equity-to-Asset falls into.



Centogene NV Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Centogene NV's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=7.851/98.318
=0.08

Centogene NV's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )=Total Stockholders Equity/Total Assets
=-16.492/77.889
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centogene NV  (NAS:CNTG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Centogene NV Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Centogene NV's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Centogene NV (Centogene NV) Business Description

Traded in Other Exchanges
Address
Am Strande 7, Rostock, MV, DEU, 18055
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.